Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

The offering was made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-219614) previously filed with the U.S. Securities and Exchange Commission.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Avital Perlman, Barrett DiPaolo and associate Yian Pan.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Represents Parsec Capital Acquisition Corp. in $86.3 Million Initial Public Offering - October 11, 2021
Sichenzia Ross Ference LLP Joins Biotricity in Ringing Opening Bell at Nasdaq MarketSite - October 7, 2021
Sichenzia Ross Ference LLP Represents American Battery Technology Company in $39.1 Million Financing - October 4, 2021

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

Related Posts